Home / Subjects / Pulmonology

Pulmonology

The study and treatment of diseases of the respiratory system.

βœ“ Introduction to Pulmonology

βœ“ Introduction to Pulmonology is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Lung Anatomy Basics

βœ“ Lung Anatomy Basics is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Lung Physiology Basics

βœ“ Lung Physiology Basics is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Asthma Basics

βœ“ Asthma Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ COPD Basics

βœ“ COPD Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pneumonia Basics

βœ“ Pneumonia Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonary Embolism Basics

βœ“ Pulmonary Embolism Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ ARDS Basics

βœ“ ARDS Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Lung Cancer Basics

βœ“ Lung Cancer Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Tuberculosis Basics

βœ“ Tuberculosis Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Interstitial Lung Disease Basics

βœ“ Interstitial Lung Disease Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Pulmonary Function Tests Basics

βœ“ Pulmonary Function Tests Basics is a core mathematics topic covering definitions, formulas, and problem-solving techniques essential for mastery.

Key points: Formal definition, derivation, worked examples, and common applications with step-by-step solutions.

βœ“ Sleep Apnea Basics

βœ“ Sleep Apnea Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonology Ethics Basics

βœ“ Pulmonology Ethics Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonology Careers

βœ“ Pulmonology Careers is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Advanced Pulmonology

βœ“ Advanced Pulmonology is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Lung Anatomy

βœ“ Lung Anatomy is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Lung Physiology

βœ“ Lung Physiology is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Asthma

βœ“ Asthma is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ COPD

βœ“ COPD is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pneumonia

βœ“ Pneumonia is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonary Embolism

βœ“ Pulmonary Embolism is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ ARDS

βœ“ ARDS is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Lung Cancer

βœ“ Lung Cancer is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Tuberculosis

βœ“ Tuberculosis is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Interstitial Lung Disease

βœ“ Interstitial Lung Disease is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

βœ“ Pulmonary Function Tests

βœ“ Pulmonary Function Tests is a core mathematics topic covering definitions, formulas, and problem-solving techniques essential for mastery.

Key points: Formal definition, derivation, worked examples, and common applications with step-by-step solutions.

βœ“ Sleep Apnea

βœ“ Sleep Apnea is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonology Ethics

βœ“ Pulmonology Ethics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

βœ“ Pulmonology Research

βœ“ Pulmonology Research is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Time complexity (Big-O), space complexity, correctness proof, and practical implementation trade-offs.

Key Clinical Formulas & Scores

CURB-65 (Pneumonia Severity):
C = Confusion (new onset) (1)
U = Urea (BUN) >19 mg/dL (7 mmol/L) (1)
R = Respiratory rate β‰₯30/min (1)
B = Blood pressure: SBP <90 or DBP ≀60 (1)
65 = Age β‰₯65 years (1)
Score: 0-1 = outpatient, 2 = admit, 3-5 = ICU consideration
Mortality: 0=0.7%, 1=3.2%, 2=13%, 3=17%, 4=41.5%, 5=57%
Well's Criteria for Pulmonary Embolism:
Clinical signs of DVT (3 pts)
PE most likely diagnosis (3 pts)
Heart rate >100 bpm (1.5 pts)
Immobilization/surgery in past 4 weeks (1.5 pts)
Previous DVT/PE (1.5 pts)
Hemoptysis (1 pt)
Malignancy (1 pt)
Score ≀4 = PE unlikely (D-dimer if negative β†’ exclude)
Score >4 = PE likely (CTPA directly)
PaOβ‚‚/FiOβ‚‚ (P/F) Ratio (ARDS Severity):
ARDS: P/F ≀300 with bilateral infiltrates, not fully explained by cardiac failure
Mild ARDS: 200 < P/F ≀ 300 (with PEEP β‰₯5 cmHβ‚‚O)
Moderate ARDS: 100 < P/F ≀ 200
Severe ARDS: P/F ≀ 100
A-a gradient = PAOβ‚‚ - PaOβ‚‚ (normal <10-15 mmHg on room air)
PAOβ‚‚ = FiOβ‚‚(PB - PHβ‚‚O) - (PaCOβ‚‚/0.8) = 0.21(760-47) - (PaCOβ‚‚/0.8)
BODE Index (COPD Prognosis):
B = BMI (≀21=1 point)
O = Obstruction (FEV₁ % predicted: β‰₯65%=0, 50-64%=1, 36-49%=2, ≀35%=3)
D = Dyspnea (mMRC scale 0-4: 0-1=0, 2=1, 3=2, 4=3)
E = Exercise capacity (6MWD: β‰₯350m=0, 250-349=1, 150-249=2, ≀149=3)
Score 0-2: 4-year mortality ~16% | Score 4-6: ~38% | Score 7-10: ~80%
GOLD Classification (COPD):
Post-bronchodilator FEV₁/FVC <0.70 confirms airflow limitation
GOLD 1 (Mild): FEV₁ β‰₯80% predicted
GOLD 2 (Moderate): 50-79% predicted
GOLD 3 (Severe): 30-49% predicted
GOLD 4 (Very Severe): <30% predicted
Symptoms: CAT score or mMRC
Exacerbations: ABE assessment β€” Group A (few symptoms, 0-1 moderate exacerbations): bronchodilator; Group B (more symptoms): LABA+LAMA; Group E (β‰₯2 moderate or β‰₯1 hospitalization): LABA+LAMA Β± ICS

Core Concepts

Asthma (GINA Guidelines)

Chronic airway inflammation with reversible airflow obstruction and bronchial hyperresponsiveness. Classification: intermittent, mild persistent, moderate persistent, severe persistent. Stepwise approach (GINA 2024): Step 1: as-needed low-dose ICS-formoterol. Step 2: daily low-dose ICS + as-needed SABA, or as-needed ICS-formoterol. Step 3: low-dose ICS-LABA. Step 4: medium-dose ICS-LABA. Step 5: high-dose ICS-LABA + LAMA Β± biologics (anti-IgE, anti-IL-5, anti-IL-4RΞ±). Exacerbation management: Oβ‚‚, nebulized SABA + ipratropium, systemic corticosteroids (prednisolone 40-50 mg Γ— 5-7 days), IV magnesium sulfate for severe.

COPD & Oxygen Therapy

Chronic bronchitis (productive cough β‰₯3 months/year Γ— 2 years) and/or emphysema (destruction of alveoli, air trapping). Smoking is primary cause (85-90%). Treatment: smoking cessation (most effective), bronchodilators (SABA, LABA, LAMA), ICS for frequent exacerbations with eosinophils β‰₯300, pulmonary rehabilitation, oxygen (PaOβ‚‚ ≀55 or SaOβ‚‚ ≀88%), lung volume reduction surgery or transplant for severe. Exacerbation: bronchodilators, corticosteroids, antibiotics if purulent sputum, NIV for acute respiratory failure (pH ≀7.35 with hypercapnia).

Pulmonary Embolism (PE)

Virchow's triad: stasis, hypercoagulability, endothelial injury. Clinical: dyspnea (most common), pleuritic chest pain, cough, hemoptysis, syncope (massive PE). Massive PE: hypotension, cardiogenic shock. Submassive: RV dysfunction (echo: RV dilation, elevated troponin, BNP) without hypotension. Diagnosis: CTPA (gold standard), V/Q scan if contraindication to contrast. Treatment: anticoagulation (LMWH β†’ DOAC or warfarin) for β‰₯3 months. Systemic thrombolysis (alteplase 100 mg Γ— 2 hrs) for massive PE. Catheter-directed therapy or surgical embolectomy if contraindications to thrombolysis. IVC filter if anticoagulation contraindicated.

Clinical Case Studies

Case 1: Community-Acquired Pneumonia

Patient: 58-year-old male, fever 39.2Β°C, productive cough with rusty sputum, pleuritic chest pain Γ— 3 days. RR 28, HR 105, BP 105/70. Crackles in right lower lobe. Labs: WBC 18,000, BUN 22, creatinine 1.1. CXR: right lower lobe consolidation with air bronchograms.

Assessment: CURB-65 = 2 (BUN >19 + RR β‰₯30 would be 3, but RR is 28 β†’ only BUN and confusion absent β†’ actually: BUN 22>19=1, no confusion=0, RR 28<30=0, BP normal=0, age 58<65=0 β†’ Score 1). Pneumonia Severity Index (PSI) Class III β€” admit.

Management: Ceftriaxone 1g IV q24h + azithromycin 500mg IV q24h Γ— 5 days. Oβ‚‚ to keep SpOβ‚‚ β‰₯92%. IV fluids. Follow-up CXR at 6 weeks if age >50 or smoker. Risk factors: smoking, age >65, comorbidities.

Case 2: Acute Pulmonary Embolism

Patient: 45-year-old female, sudden dyspnea and pleuritic chest pain Γ— 6 hours. HR 118, RR 28, SpOβ‚‚ 91% on room air. PMH: obesity (BMI 38), oral contraceptive use, recent long-haul flight. Wells score = 7.5 (signs of DVT 3 + PE likely 3 + HR>100 1.5). CTPA: large filling defect in right main pulmonary artery extending into lobar branches. Echo: RV dilation, elevated troponin 0.8.

Diagnosis: Submassive (intermediate-high risk) PE β€” RV dysfunction + positive biomarkers without hypotension.

Management: Therapeutic anticoagulation: enoxaparin 1 mg/kg SC q12h or rivaroxaban 15 mg BID Γ— 21 days then 20 mg daily. Oβ‚‚ therapy. Hemodynamic monitoring. No systemic thrombolysis (not massive PE). If clinical deterioration β†’ rescue thrombolysis. Discharge when stable on DOAC (if no RV dysfunction, can discharge early). Minimum 3 months anticoagulation; indefinite if unprovoked or recurrent.

Case 3: COPD Exacerbation with Respiratory Failure

Patient: 72-year-old male, COPD (GOLD 3, FEV₁ 42%), presents with increased dyspnea, purulent sputum Γ— 5 days. ABG on 2L NC: pH 7.28, PaCOβ‚‚ 68, PaOβ‚‚ 52, HCO₃ 32. SpOβ‚‚ 88%. Bilateral wheezes, prolonged expiratory phase.

Diagnosis: Acute exacerbation of COPD (AECOPD) with acute on chronic respiratory acidosis (pH <7.35 + PaCOβ‚‚ >45 = NIV indicated).

Management: NIV (BiPAP: IPAP 10-15, EPAP 4-5) β€” reduces intubation and mortality. Nebulized salbutamol + ipratropium q1h. IV methylprednisolone 40mg daily Γ— 5 days. Antibiotics: azithromycin 500mg daily Γ— 5 days (purulent sputum). Controlled oxygen therapy (Venturi mask 24-28%, target SpOβ‚‚ 88-92%). Avoid high-flow Oβ‚‚ (risk of COβ‚‚ narcosis). If NIV fails or pH <7.25 β†’ intubation and mechanical ventilation.

Practice Questions

Q1: A 75-year-old with pneumonia has confusion, RR 32, BP 88/58, BUN 25. What is the CURB-65 score and disposition?
A: Score = 4 (confusion 1 + RRβ‰₯30 1 + BP<90/60 1 + ageβ‰₯65 1). High risk β€” admit to ICU. Mortality ~41%.
Q2: A patient has PaOβ‚‚ 65 mmHg on FiOβ‚‚ 0.5. What is the P/F ratio and ARDS severity?
A: P/F = 65/0.5 = 130. Moderate ARDS (100 < P/F ≀ 200).
Q3: What is the mechanism of action of NIV (BiPAP) in COPD exacerbation?
A: NIV reduces work of breathing, improves alveolar ventilation (washes out COβ‚‚), recruits collapsed alveoli, and unloads respiratory muscles. Indicated when pH ≀7.35 with hypercapnia despite optimal medical therapy.
Q4: A patient with PE has a Wells score of 6. What is the next step?
A: Wells score >4 = PE likely β†’ proceed directly to CT pulmonary angiography (CTPA). No D-dimer needed.
Q5: What is the target oxygen saturation in COPD patients with chronic hypercapnia?
A: 88-92%. Higher FiOβ‚‚ can suppress hypoxic drive, worsen V/Q mismatch, and cause COβ‚‚ narcosis. Use controlled oxygen therapy (Venturi mask or 2L NC) and monitor ABG.

πŸ“š Related Subjects

All Subjects

Categories

Get Premium